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A Novel Bioreactor System for the 
Assessment of Endothelialization 
on Deformable Surfaces
Björn J. Bachmann1,*, Laura Bernardi2,*, Christian Loosli3,*, Julian Marschewski1, 
Michela Perrini2,4, Martin Ehrbar4, Paolo Ermanni3, Dimos Poulikakos1, Aldo Ferrari1 & 
Edoardo Mazza2,5
The generation of a living protective layer at the luminal surface of cardiovascular devices, composed 
of an autologous functional endothelium, represents the ideal solution to life-threatening, implant-
related complications in cardiovascular patients. The initial evaluation of engineering strategies 
fostering endothelial cell adhesion and proliferation as well as the long-term tissue homeostasis 
requires in vitro testing in environmental model systems able to recapitulate the hemodynamic 
conditions experienced at the blood-to-device interface of implants as well as the substrate 
deformation. Here, we introduce the design and validation of a novel bioreactor system which enables 
the long-term conditioning of human endothelial cells interacting with artificial materials under 
dynamic combinations of flow-generated wall shear stress and wall deformation. The wall shear stress 
and wall deformation values obtained encompass both the physiological and supraphysiological range. 
They are determined through separate actuation systems which are controlled based on validated 
computational models. In addition, we demonstrate the good optical conductivity of the system 
permitting online monitoring of cell activities through live-cell imaging as well as standard biochemical 
post-processing. Altogether, the bioreactor system defines an unprecedented testing hub for potential 
strategies toward the endothelialization or re-endothelialization of target substrates.
Statistical predictions for the ageing population of Western Countries foresee a dramatic increase of cardiovas-
cular patients in the next two decades, which will manifest itself as a rapidly growing public health issue with 
significant economic impact1. In particular, almost 40 million people are expected to suffer of heart failure and 
related complications2.
Heart transplantation is the current treatment option in case of severe heart failure, however it is limited by 
donor heart availability and patient eligibility3. Recent developments in circulatory support system technology 
have established ventricular assist devices (VADs) as a viable bridge-to-transplant solution4. The further develop-
ment of VADs into destination therapy, and thus their deployment as a substitute for transplantation, is hindered 
by the excessive incidence of device-related adverse events5. One of the main complications in state-of-the-art 
VADs is blood coagulation triggered by the contact between blood and artificial materials comprising the device 
which is partially restrained by intense administration of blood thinners in turn exposing the patient to hemor-
rhagic events6–8.
The long term integration of cardiovascular devices can be obtained through the formation of a living protec-
tive layer, generated by autologous endothelial cells (ECs), at the implant’s luminal surface9. Several strategies have 
been proposed to address the process of endothelialization of artificial materials (i.e. metal alloys, plastic polymers, 
and elastomers). These include the chemical modification of synthetic interfaces in contact with blood10, the sur-
face structuring with rationally engineered topography11–13, or the biological functionalization with intervening 
layers of basal matrix components or biological molecules promoting the binding and proliferation of ECs14. 
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The common goal of these approaches is to promote specific endothelial activities, overall supporting the gen-
eration and long-term maintenance of a functional monolayer, in order to support the establishment of local 
homeostasis and prevent the direct contact between blood and artificial materials15,16. Despite significant techno-
logical advancements, a viable endothelialization protocol is still missing. The luminal endothelialization of car-
diovascular implants remains anecdotal and largely insufficient to cope with the high number of post-deployment 
complications in cardiovascular patients17,18.
Endothelialization strategies are initially developed based on in vitro tests, which often fail to recapitulate 
the complex environment experienced by ECs at the interface between blood and synthetic materials in vivo9. 
Perhaps the most important regulator of endothelial function, from adhesion to polarization, stems from the 
hemodynamic conditions generated by the local pattern of blood flow, the wall geometry, and the deformability 
of the wall materials19. The temporal variations and absolute magnitude of flow-generated wall shear stress (WSS) 
and wall deformation (WD) showed a critical impact on all tested ECs activities20–22. In particular, the migration 
and polarization of ECs are directly modulated by the direction and time pattern of flow23,24. The stability of sub-
strate adhesions and Vascular Endothelial Cadherin (VEC)-based cell-to-cell junctions is controlled by the abso-
lute WSS value25,26. The EC migration potential upon wound healing is regulated by the flow direction and the 
resulting WSS values11,23. The monolayer response to inflammatory insults similarly depend on flow directionality 
and WSS. EC polarization is dictated by the direction of flow and of substrate deformation27.
Partial access to physiological hemodynamic conditions has been introduced through bioreactors able to pro-
duce dynamic patterns of WSS23,28, uni- or biaxial stretch (summarized recently in refs 29 and 30) or some combi-
nation of these31,32. Only few examples reported the concomitant application of flow and uniaxial strain33–36 on ECs 
but did not explore WSS values higher than 2 Pa. Existing devices do not allow to study the endothelial response 
to WD and WSS in a range comparable to that experienced by ECs at the luminal surface of passive arterial grafts 
or active deformable elements of VADs30. Specifically, WSS in the range up to 10–15 Pa are present in VADs37,38 
in regions identified as possible sources of thrombus formation37. Pulsatile VADs generate complex pattern of 
WSS and WD on the propulsion membrane with values close to the physiological range, i.e. up to 15% strain 
for WD (see e.g. ref. 39) and 6 Pa for WSS40. The two stimuli can be reproduced in existing bioreactors but with 
limitations in the magnitude: Amaya et al.41 developed a combined system for which WD is up to 20% but WSS 
is limited in the range between 0 and 2 Pa; the device by Dancu and Tarbell42 is also limited in WSS (max 2 Pa). 
The company Flexcell proposes a system where the maximum strain applicable is 4% (http://www.flexcellint.com/
FlexFlow.htm).
A custom-developed, parallel plate flow bioreactor yielding extended control over physiological and supra-
physiological WSS values (up to 12 Pa) was recently introduced43. This bioreactor enabled the study and valida-
tion of endothelialization strategies under WSS conditions reproducing those expected in pumping systems such 
as VADs44. Endothelial response to WD in the range of those experienced at the luminal surface of passive arterial 
grafts or active deformable elements of VADs as well as the effect of complex time patterns of combined WSS and 
WD were largely neglected due to the challenges connected to the development of a reliable bioreactor with such 
capabilities30.
We hereby introduce a novel, custom-designed flow bioreactor system, enabling the long-term in vitro testing 
of endothelialization strategies for a broad range of complex realistic physiological and supraphysiological flow 
conditions. The system enables the independent control of WSS (up to 20 Pa) and WD (with uniaxial and biaxial 
strain up to 20%) yielding a wide range of spatiotemporal gradients of mechanical stimulation on endothelial 
monolayers, which encompass the hemodynamic conditions experienced at the luminal interface of VADs. The 
system is optically conductive and therefore accessible by high-resolution microscopes for online inspection of 
endothelial activities. The overall design and implementation of the system presented and its validation is exem-
plified with respect to the assessment of endothelialization of artificial materials obtained using primary human 
endothelial cells (HUVECs) which are exposed to a range of stimulations for prolonged periods of time (up to 
24 h). These new experiments also reveal novel insights into the response of ECs to overlapping gradients of WSS 
and WD requiring further dedicated investigations.
Results
Working principle of the reactor system. The system applies a cyclic predefined state of deformation to 
an elastomeric membrane covered by endothelial cells (ECs). This Wall Deformation (WD) displaces the mem-
brane generating a partial obstruction of the flow in the chamber. In this manner the ECs are exposed to a con-
trolled time-variable flow field leading to specific pattern of Wall Shear Stress (WSS) on the cell layer. The realized 
concomitant and time-variable WD and WSS, are representative of a variety of conditions experienced by ECs in 
heart ventricles, large vessels, and cardiovascular devices.
Design and operation. The reactor was designed to generate a range of complex combinations of mechan-
ical loading through the independent control of WSS and cyclic mechanical stretch (i.e. WD) on ECs (Fig. 1). 
The dynamic ranges of WSS and WD were selected to encompass the physiological values experienced by ECs 
in the human circulation (i.e. WSS values up to 6 Pa and WD values up to 10%). In addition, the bioreactor was 
designed with the unique capability of generating supraphysiological hemodynamic conditions similar to the 
ones expected at the luminal surface of VADs (i.e. WSS higher than 6 Pa and WD up to 20%). Finally, the mate-
rials and the overall bioreactor geometry were chosen to maximize optical access to the region housing the ECs 
(Fig. 1).
Figure 1 schematically illustrates the overall reactor design. Two main, independently-controlled compart-
ments are displayed (Fig. 1C,D). The first corresponds to a flow chamber housing the ECs during the flow- 
conditioning experiments (Fig. 1C). The chamber features external dimensions of 25 × 60 mm and an internal 
rectangular cross section of 6 × 2.5 mm2. The inlet and outlet of the flow chamber are placed at the extremities and 
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connect to the peristaltic pumping device to generate a fully-developed flow of cell culture medium on the central 
region of the chamber and therefore yielding a desired WSS on EC monolayers.
The second element is an inflation system that actuates cyclic stretch on the deformable membrane covered 
by ECs (Fig. 1D). The membrane is comprised of a PDMS-based elastomer, which faces the flow chamber and 
supports the endothelial monolayer at its luminal surface. The membrane inflation system is composed of a cyl-
inder of 15 mm outer diameter and 5 mm inner diameter fixed to the flow chamber by 4 screws (Fig. 1B). The 
volume of liquid (i.e. PBS) inside the cylinder is controlled with a syringe pump receiving online feedback from a 
pressure sensor. The luminal end of the cylinder extends towards the flow section and is separated from it by the 
interfacing deformable membrane. Therefore, the hydrostatic pressure in the cylinder actuates the cyclic inflation 
of the membrane during the experiment. In this manner, a controlled state of biaxial deformation is applied to 
the ECs (Fig. 1E,F).
Control and Validation. The reactor system is actuated by two independently-controlled pumps that can 
operate individually (Fig. 2). When running on a single pump the reactor performs either as flow chamber expos-
ing the endothelial monolayer to defined WSS, or alternatively as pure stretching device yielding uniaxial and 
biaxial WD. The validation of the device reported in the following was performed first for the single components 
operating individually and, in a second phase, for the combined modality of operation. In the flow-only config-
uration, omitting the metal disk allows to generate higher WSS levels. The components and the assembly of the 
reactor are illustrated in Supplementary Video 1. The dynamics in the flow chamber were characterized by a com-
putational fluid dynamics simulation (CFD, see Methods and Supplementary Video 2), which was experimentally 
supported by corresponding microparticle image velocimetry (μ PIV) measurements in the channel (Fig. 3). For 
the configuration with no metal disk and a flat membrane, we simulated steady-state flow patterns within the 
fluidic channel under the assumption of a fully-developed flow. The good agreement with the results from the μ 
PIV measurement (Fig. 3A) shows that the system is capable of applying up to 13 Pa of WSS on the cells located 
in the central housing of the channel in this configuration (Fig. 4A).
These results demonstrate that the flow in the reactor is suitable for testing the effect of both physiological 
and supraphysiological flow conditions on ECs. In addition, to exclude possible fluid flow fluctuations generated 
by the peristaltic pump, a turbine flow sensor was inserted in the flow channel. The experimental measurements 
retrieved confirmed that flow fluctuations did not exceed 15% of the set value during long-term operation of the 
flow system (Supplementary Figure 1).
For the various membrane configurations with the metal disk present, different conditions apply. During 
the stretching loop, the deformable PDMS membrane cycles between two states: the flat state (Fig. 1E) during 
which the substrate is in its reference configuration (i.e. no WD), and the inflated state (Fig. 1F) during which 
the maximal imposed stretch is reached (i.e. maximal WD). To regulate the time history of fluid pressure applied 
in the inflation system over the whole duration of a conditioning experiment a dedicated control algorithm was 
Figure 1. Design of the System. (A) Bioreactor chamber dimensions. l = 47 mm (entrance length); h = 2.5 mm 
(chamber height); w = 6 mm (chamber width, not shown) and d = 5 mm (diameter of the inflated membrane). 
(B) Global cross section view of the bioreactor. (C) View of the reactor with transparent inflation part.  
(D) View of the reactor with transparent flow part. The insets show the membrane (clamped in between Metal 
disk and O-Ring) in its flat state (E), corresponding to the minimum shear stress, and its maximum inflated 
state (F) that corresponds to the maximum shear stress conditions. The scale bars in panels (A–D) correspond 
to 10 mm and the scale bars in panels (E) and (F) to 5 mm, respectively.
www.nature.com/scientificreports/
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developed. The stretch of the membrane is actuated by the movement of liquid in and out of the inflation cylinder 
establishing a pressure load on the elastomer. In particular, the flat and the inflated states of the membrane cor-
respond to the start and end positions of the syringe pump piston, respectively (Supplementary Figures 2 and 3). 
The level of deformation of the membrane depends on the pressure generated in the inflation cylinder and is 
controlled based on corresponding model equations. The cyclic inflation (from flat to inflated) occurs at a defined 
frequency in the range between 0.85 and 1.1 Hz. The maximum inflation as well as the inflation frequency are 
selected for each experiment through the corresponding parameters in the control software (Supplementary  
Figures 3 and 4).
Supplementary Figure 2 summarizes the results of a validation test for the inflation system and the corre-
sponding control algorithm. For this test the system was set to reach 220 mbar yielding a maximal principal 
strain of (approximately) 8% with a cyclic stretch frequency of 1 Hz. These conditions were selected to repre-
sent elevated physiological values of stretch and frequency. During the test the pressure was measured by a 
membrane-deformation pressure sensor with a sampling frequency of 10 Hz that was connected to the inflation 
chamber and supplied to the control algorithm. In the control feedback loop the software compared the maxi-
mum pressure acquired in a time frame of 10 s to the target maximum pressure and used the magnitude of the dif-
ference (with a 5 mbar tolerance) to adjust the end position of the syringe pump piston (Supplementary Figure 4). 
The effect of the adjustment was then measured (with an accuracy of ± 1.5%) over the next 10 s, before starting 
a new control loop. At the same time the starting position of the syringe pump piston defines the reference con-
figuration in which the deformable membrane should be in a flat state. In case that at this point the measured 
reference pressure was negative (< 0 mbar), the starting position of the piston was adjusted. In all, these results 
demonstrate that the system was able to constantly maintain the pressure between the set values (i.e. 0 ± 5 and 
220 ± 5 mbar) for more than 105 cycles thus establishing the long-term stability of the cyclic stretch actuation of 
the reactor.
Figure 2. Control of actuation. The set-up consists of two independently controlled components. The inflation 
cylinder is actuated by a syringe pump (A). The pressure in the inflation cylinder is monitored by a sensor  
(B) and controlled via a custom-developed LabView software. The flow chamber is actuated by a peristaltic 
pump connected to a compliance (C) and a reservoir (D).
www.nature.com/scientificreports/
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Actuation of the inflation device yielding multiaxial stretch of the deformable membrane was validated 
through a finite element (FE) model yielding the strain field on the membrane for each combination of thickness 
and pressure, as well as the maximum membrane apex displacement. These results were directly compared to 
measurements obtained by digital imaging correlation (DIC, see Materials and Methods). As reported in Fig. 5, 
good agreement in terms of both displacement and strain was reached. In particular, for the case of a 500 μ m 
thick membrane inflated with 220 mbar, a deviation of 1 μ m (corresponding to less than 1%) in the out-of-plane 
displacement was observed. Regarding the strain field, the discrepancy between the two reported methods was 
slightly larger (up to 1% strain) but still within the experimental uncertainties. These results demonstrate that 
the stretch component of the reactor is suitable for applying predefined deformation pattern and thus testing the 
effect of a wide range of WD (i.e. physiological and supraphysiological) on ECs.
When both components of the reactor are actuated, inflation of the deformable membrane into the flow cham-
ber generates a dynamic combination of asymmetric WSS and multiaxial WD on the luminal surface of the 
deformable membrane. Specifically, the system cycles between the flat state (i.e. no WD, Fig. 1E) in which the 
surface of the deformable membrane only experiences the WSS imposed by the actuation of the flow channel, 
and a fully inflated state (i.e. maximal WD, Fig. 1F) in which the maximal WD is superimposed. The membrane 
bulging into the fluid stream interacts with the flow pattern to generate areas of high WSS on the upstream half of 
the deformable membrane and regions of recirculation and low WSS in the downstream half. The resulting redis-
tribution of the WSS pattern upon the membrane inflation cycle was evaluated through in silico numerical sim-
ulations for various flow conditions and experimentally confirmed by μ PIV measurements (Fig. 3). Importantly, 
the combined actuation of the two reactor systems creates areas of the deformable membrane which, in the fully 
Figure 3. Validation of the velocity field. Comparison of Computational Fluid Dynamics (CFD) and 
Microparticle Image Velocimetry (μ PIV) flow profiles at 0.4 l/min flow. (A) CFD (red circles) and μ PIV (blue 
rhombus) profiles for the flat membrane configuration. (B–D) Corresponding profiles for the configuration 
with membrane inflated to 20% extension (i.e. 720 mbar) at the inlet (B), center (C), and outlet (D), respectively.
www.nature.com/scientificreports/
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inflated state, are exposed to higher (in the front) or lower (in the rear) values of WSS, as compared to those 
defined by the sole actuation of the flow channel with identical flow.
Assessment of endothelialization. We next set to validate the reactor for the assessment of endotheli-
alization under loading conditions simulating the values which are expected in regions of implanted VADs. In 
particular, during the cell-conditioning experiments, a time-dependent WSS and WD field were created on a 
fully differentiated and growth-arrested endothelium generated in static conditions at the luminal surface of the 
deformable membrane (Supplementary Figure 6). For this validation, flow values to yield maximum WSS encom-
passing the physiological and supraphysiological range (i.e. from 0.5 to 10) were selected. In addition, the inflation 
cylinder was actuated at a frequency of 1 Hz to reach a maximal pressure of 220 mbar, leading to an equibiaxial 
strain at the apex of approximately 8% in the fully inflated state. After starting the flow in the flow channel at 
Figure 4. WSS profiles in the reactor. (A) Maximum (red circles), average (green circles), and minimum 
(blue circles) WSS at the surface of the deformable membrane as a function of pure flow rate (flow rates from 
0.1 l/min to 1.5 l/min) in the flat membrane configuration. (B) Maximum WSS at the surface of the deformable 
membrane as function of the flow rate and for different membrane strain conditions ranging from flat (pink 
circles) up to surface strain of 15% (green triangles).
www.nature.com/scientificreports/
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the beginning of the conditioning experiment, the maximum pressure in the inflation cylinder was gradually 
increased to the target value, in order to avoid damage to the cells due to sudden stretch increase. The target 
pressure was typically reached within 5–10 min from the beginning of the experiment (Supplementary Figure 2).
At the end of the conditioning experiments, the quality and functionality of the endothelial monolayer cov-
ering the deformable membrane was evaluated. Specifically, values for cell coverage, density, and orientation 
were obtained by staining ECs for filamentous actin, Vascular Endothelial Cadherin (VEC) and cell nuclei43 
(Supplementary Figure 6).
Endothelial monolayers exposed to WD under flow rates yielding physiological WSS values along the entire 
inflation cycle of the deformable membrane (i.e. 0.2 and 0.4 l/min) were able to withstand the load and maintain 
full coverage and connectivity over the entire target substrate (Fig. 6A,B). Importantly, higher flow rates (i.e. 0.6 
and 1.2 l/min, Fig. 6C,D) generated areas of the deformable membrane, which were exposed to supraphysiological 
WSS values (between 6 and 26 Pa) values in the fully inflated state (Fig. 4). In these regions endothelialization 
was compromised, creating areas of the deformable membrane partially or fully depleted of cells (Fig. 6C,D). This 
process could be visualized through live-cell microscopy (Supplementary Videos 3 and 4). Time-lapses obtained 
at regions of supraphysiological WSS revealed that cell loss in these areas was the result of cell migration along 
a WSS gradients, with ECs moving toward regions of lower WSS (Supplementary Video 4). In all, this data con-
firms the viability of the system to study the effect of combined WSS and WD loading on the endothelialization 
of artificial materials showing a striking agreement between the computed values of WSS and the resulting effect 
on endothelialization (Figs 6 and 7). Furthermore, it suggests that the effect of the selected moderate values of 
circumferential stretch was not causing cell depletion if not combined with complex patterns of elevated WSS on 
the target surface. Emerging regions of supraphysiological WSS corresponded to areas of endothelialization loss 
and local gradients of WSS were able to direct cell migration.
To obtain further insight into the effect of WSS gradients and of flow dynamics on the evolution of endothelial 
coverage of the target deformable target membrane we investigated the case of cells exposed to the combination of 
0.4 l/min flow rate and 8% maximal deformation (Fig. 7). Here, the resulting patterns of cell alignment to flow could 
be distinguished in three regions which coincide with regions featuring different values of WSS (Figs 7 and 8). In 
regions of the monolayer which are exposed to low, physiological WSS values (i.e. between 0.1 and 4 Pa, Fig. 7A) all 
through the deformation cycle cells aligned along the direction of flow (flanking regions of the deformable mem-
brane, Fig. 8). ECs exposed to high, physiological WSS (between 4 and 6 Pa) in the fully inflated state aligned per-
pendicular to the flow which is in agreement with what was previously reported (ref. 45 and Fig. 8). Here, cell density 
was increased, while cell area did not change significantly (Fig. 7C,D). Finally, the rear region of the deformable 
membrane, exposed to low WSS values and flow recirculation in the fully inflated state featured an area of the mon-
olayer which was characterized by high density of cells forming a ring along the recirculation profile (Figs 7A and 8). 
Figure 5. Validation of the inflation cylinder. Comparison between Digital Image Correlation (DIC) results 
for a 500 μ m thick membrane loaded with 220 mbar pressure and the corresponding Finite Element Model 
(FEM). Top: Z displacement. The max displacement given by the DIC measurement is 0.615 mm; the predicted 
FE displacement is 0.614 mm. Bottom: Strain. The apex strain given by the DIC measurement is 7.7%; the 
predicted FE maximum strain is 8.4%.
www.nature.com/scientificreports/
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Figure 6. Endothelialization under complex hemodynamic conditions. (A–D) WSS patterns computed 
for the combined actuation of the flow channel and the inflation cylinder for an imposed flow of 0.2, 0.4, 0.6, 
and 1.2 l/min, respectively (left). The WSS maps correspond to the fully inflated state for a target of 8% cyclic 
biaxial strain. The dashed white line delimits regions that feature more than 5 Pa WSS. The right column reports 
the filamentous actin staining on HUVECs cells on a 5 mm diameter PDMS deformable membrane after 18 h 
conditioning. Note that at flow rates of 0.6 l/min (C) and higher (D) endothelialization was absent in the region 
of the membrane exposed to supraphysiological WSS. Corresponding high-resolution images are provided as 
Supplementary Figures 8–11.
www.nature.com/scientificreports/
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These data indicate that a number of parameters have an active effect on the response of ECs to complex flow pat-
terns, including absolute WSS and WD values, spatial and temporal gradients of WSS, and local flow direction.
Discussion
In summary, the various elements of the work substantiate the introduced novel reactor system as a valuable plat-
form to test the endothelialization of artificial materials under physiological and supraphysiological conditions 
of mechanical loading. In the reactor, primary human endothelial cells can be exposed to varying combinations 
of flow-generated WSS and WD for long periods of time and the maintenance of a confluent and functional 
endothelial monolayer can be assessed in vitro. The reactor’s optical access allows live cell and flow monitoring 
and thus the evaluation of endothelial cell response to flow and deformation.
The overall modular structure of the reactor enables independent control of the flow conditioning system 
(up to a target WSS of 20 Pa) and of the stretch device (up to a target deformation of 20%). Both elements can 
be fully operated in single modality, therefore yielding pure flow or pure stretch stimulation to endothelial cells 
(Figs 1 and 2). A specific novelty of the presented system is represented by its simultaneous actuation, which 
generates complex flow patterns on the deformable membrane supporting endothelial cells (Fig. 6). Owing to 
the geometry of the flow channel and of the deformable membrane inflation, the spatial variation of WSS during 
the inflation cycle can be reliably predicted by computational simulation, which are confirmed by the values 
obtained by experimental visualization (Figs 3, 4 and 6). Compared to other devices41,42, combined activation of 
flow and inflation systems allows to generate a wider range of conditions of cyclic WSS and multiaxial WD. Our 
Figure 7. Effect of complex WSS and WD patterns on surface endothelialization. (A) Fluorescent images 
of an endothelium covering the deformable membrane after 18 h of flow conditioning at 0.4 l/min and 
membrane deformation at 8% maximal strain and 1 Hz frequency. (Red = Actin, Blue = Nuclei, Green = VEC). 
(B) Three regions of interest (I, II, and III) were selected corresponding to areas exposed to different WSS in 
the fully inflated state of the deformable membrane (Fig. 1F). (C) Corresponding measure for cell area and 
(D) cell density. Significant differences for the cell area are reported (*for α < 0.05). n denotes the number of 
independent experiments and n′ denotes the number of measured cells. Error bars correspond to the standard 
error of the mean. (E) The rose plots report the measured cell alignment (tracking) to the direction of flow as 
predicted by CFD analysis (CFD).
www.nature.com/scientificreports/
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system cannot provide homogeneous conditions of WSS and WD on the membrane of the bioreactor. The spatial 
variations of shear stress and strain are similar to those present in heart ventricles, in larger vessels as well as in 
Figure 8. Endothelial cell alignment to flow. Zoomed immunofluorescent images of the endothelium in the 
regions of interest defined in Fig. 7 (Actin, VEC and Nuclei) and corresponding visualization of tracked cell 
alignment (line plot) and CFD flow direction predictions. Scale bar is 200 μ m. Corresponding high-resolution 
images are provided as Supplementary Figures 12–20.
www.nature.com/scientificreports/
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VADs37–40. It thus allows investigating the influence of WD and WSS gradients on cell survival, functionality, 
shape, orientation and density.
We report experiments which confirm the viability of the system at hand to study the response of endothelia 
covering an artificial elastomeric membrane exposed to complex loading conditions for several hours (Fig. 6). 
The maintenance of the endothelial integrity and function is assessed both live to capture events such as cell 
migration or loss of adhesion and through end-point biological analysis to reveal the expression and localization 
of specific endothelial markers. Endothelial cells contacting flat artificial surfaces can withstand WSS values in 
the physiological range. In fact, the presence of physiological flow was found to enhance viability and has thus 
found application in tissue engineering46. In addition, at low to medium values (up to 5 Pa) the cells adapt to flow 
by orienting their shape along the direction of flow (Figs 7 and 8). At higher values endothelial cells initially orient 
perpendicular to flow, and subsequently lose adhesion and detach from the substrate leading to the formation of 
regions of the endothelium with compromised integrity and/or coverage47,48.
These characteristic endothelial responses to flow at the interface with artificial materials are well reproduced 
(Figs 6 and 7). The spatial and temporal variations of WSS generated by the superimposed inflation of the deform-
able membrane have a twofold effect. First, they create a time-dependent asymmetry of WSS on the surface of the 
deformable membrane. In the inflated state the upstream region and the cells adhering to it are exposed to higher 
levels of WSS than the downstream region where low WSS values and flow recirculation are generated (Fig. 6). 
The emergence of areas of supraphysiological WSS creates weak points of endothelialization where cells are lost 
and a direct contact between the flowing medium and the artificial materials is possible. Second, it provides an 
additional mechanical stimulation to cells adhering to the substrate, which have to adapt to the circumferential 
gradient of deformation. The overlapping of WSS and WD gradients may generate directional signals for migra-
tion, which can induce polarized cell movements yielding local changes in cell density (Fig. 7 and Supplementary 
Video 4).
Current endothelialization strategies that can be tested in the novel reactor system include rationally-designed 
surface topographies43,45 promoting endothelial adhesion and migration (which can be introduced on the elas-
tomeric membrane by means of standard soft lithography49, coatings with matrix proteins cross-linked to the 
elastomer50, or intervening layers of polymers deposited by means of electrospinning and directly bonded to the 
PDMS51).
Altogether, the reactor is instrumental in decoupling the effects of a broad range of hemodynamic parameters 
on endothelial cells at the interface with artificial materials. Therefore, it provides an exciting platform for the 
study of fundamental cell activities and the validation of solutions aimed at creating a stable protective layer on 
artificial materials at the luminal surface of cardiovascular implants.
Methods
Fabrication and actuation. The combined flow-deformation bioreactor system can be divided in two main 
components, the flow chamber and the inflation cylinder (Figs 1 and 2). Both components were fabricated using 
a 3D-printing system (Objet 500 Connex™ , Stratasys, PolyJet technology) employing the acrylic based polymer 
VeroWhitePlus RGD835 (Stratasys). Two round glasses (1 mm thickness) were glued to the inflation cylinder and 
to the flow chamber, respectively, in order to guarantee optical access to a deformable membrane placed at the 
interface between the two systems and supporting a layer of cells in endothelialization experiments (Fig. 1). The 
membrane, comprised of an elastomeric layer, was tightly pressed against a metal disk of outer and inner diameter 
of 15 mm and 5 mm diameter, respectively (Fig. 1). Sealing was obtained with an O-ring interposed between the 
membrane and the cylinder.
The flow of culture medium in the flow chamber was generated by a peristaltic pump (P1500, Harvard 
Apparatus) equipped with 7.9 mm inner diameter Tygon tubes (Harvard Apparatus). The pump was periodically 
calibrated and the flow rate for each experiment was selected using the pump control functions. The cell medium 
was stored in a reservoir upstream of the pump, while a compliance downstream of the pump, placed before the 
bioreactor, was used to dampen the intrinsic pulsatility of the peristaltic propulsion (Fig. 2). The liquid in the 
inflation cylinder (i.e. PBS) was actuated through a syringe pump (PSD/4 HAMILTON, Bonaduz) equipped with 
a 5 ml glass syringe. The pressure level of the PBS inside the inflation cylinder was measured through a pressure 
sensor (MPX 4250 AP, Freescale). The syringe pump was connected to a reservoir filled with PBS (Sigma).
Fabrication of the deformable membrane. Polydimethylsiloxane (PDMS, Dow Corning, Sylgard 184) 
membranes with a thickness of 400 ± 20 μ m and 500 ± 20 μ m were fabricated by curing a 10:1 mixture of base to 
crosslinker in between two soap-dipped glass plates separated by a teflon spacer of the respective thickness. This 
method was adapted from ref. 52 and yielded membranes with an elastic modulus of 1.09 MPa53. The thickness h 
was verified by determining cross sections at 8 to 9 different, preselected points with a microscope in brightfield 
mode (LSM 5 Pascal, Carl Zeiss GmbH, Jena, Germany). The precision of the resulting measurement was approx-
imately 0.01 mm.
Optical transparency. The optical transparency across the reactor in the 450–780 nm optical window was 
assessed by means of a home-built inverted microscope equipped with a spectrometer (Princeton Instruments). 
The fully mounted bioreactor was placed with the luminal side of the deformable membrane facing the incoming 
light beam. A 10X air objective (Olympus MPlan N, 0.25 NA) was used to illuminate the sample with normal 
incidence angle and collect the reflected and scattered light. White light from a xenon lamp was brought to the 
set-up with an optical fiber (105 μ m core size) in order to improve its spatial coherence. To calculate the absorp-
tion spectrum, the relation
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I (1)
was used, where A, I, and R are the absorption, incident (excitation), and reflected spectra, respectively. Dark 
counts of the spectrometer and background spectra were subtracted from all the measured spectra.
Cell culture. Human umbilical vein endothelial cells (HUVECs; ThermoFisher Scientific, USA) were grown 
in medium M200PRF supplemented with fetal bovine serum 2% v/v, hydrocortisone 1 mg/ml, human epider-
mal growth factor 10 ng/ml, basic fibroblast growth factor 3 ng/ml54,55, and heparin 10 mg/ml (all reagents from 
ThermoFisher Scientific) and were maintained at 37 °C and 5% CO2. All reported experiments were performed 
using cells with less than seven passages in vitro.
The deformable membranes were sterilized by overnight treatment with ethanol and rinsed three times with 
PBS before starting the coating procedure. The substrates were then coated with gelatin according to the protocol 
by ref. 56. The substrates were stored at 4 °C until the seeding of the cells. Cells were seeded on the substrates at 
high density (3.5–5 × 104 cells/cm2). The substrates were then cultured for three days to generate a fully confluent 
and growth-arrested monolayer57.
Substrate endothelialization. The bioreactor was placed under a wide-field Nikon-Ti microscope 
equipped with an incubation (Life Imaging Services, Switzerland) chamber maintaining a 37 °C and 5% CO2 envi-
ronment. Prior to the insertion of the deformable PDMS membrane supporting a growth-arrested, differentiated 
endothelium, the bioreactor was sterilized by flushing all inner cavities with 70% ethanol. Luminal surfaces were 
then rinsed three times with PBS before filling the system with fresh medium. At this point the PDMS membrane 
supporting a layer of endothelial cells was mounted in the system under sterile conditions. The syringe pump 
providing the inflation was started and the inflation volume was ramped up until the required pressure generating 
the desired principal strain was reached. Afterwards, the desired flow rate was set and the cells were subjected to 
the flow for a minimum of 18 h. A PVDF flow sensor (PVDF Chemical Flowmeter 0.025–2.5 l/min, B.I.O-TECH 
e.K., Germany) was used to measure flow rate and fluctuation.
Immunostaining. The following primary antibody was used: goat anti-VEC (Vascular Endothelial Cadherin; 
#6458) from Santa Cruz Biotechnology Inc. (USA). The secondary antibody was a Rabbit anti-Goat IgG (H + L) 
Superclonal Secondary Antibody, Alexa Fluor 488 (#A27012) conjugate from ThermoFisher Scientific (USA).
HUVECs were fixed and permeabilized for 10 min with 3% paraformaldehyde (PFA) and 0.1% Triton-X100 in 
PBS at room temperature (RT). The cells were then post-fixed with 3% PFA in PBS for 15 min. After washing the 
samples three times for 5 min with PBS, they were incubated with 5% bovine serum albumin (BSA) in PBS for 2 h 
at RT. The samples were incubated with TRITC-phalloidin (Sigma, USA) and goat anti-VEC primary antibody 
overnight at 4 °C. Subsequently, the samples were rinsed four times for 1 h each with 5% BSA in PBS and then 
were incubated with anti-goat-alexa-488 secondary antibody for 45 min at RT. Finally, the samples were washed 
three times (1 h each) in PBS, post-fixed for 2 min in 3% PFA, briefly washed again with PBS, mounted with 
Fluoroshield histology mounting medium (Sigma, USA) and imaged immediately.
Image acquisition. The immunostained samples were imaged using an inverted Nikon-Ti spinning disk 
confocal microscope (Nikon, Japan) equipped with an Andor DU-888 camera (Oxford Instruments, United 
Kingdom) and a pE-100 LED illumination system (CoolLED Ltd, Andover, United Kingdom). Fluorescent 
images of immunostained HUVECs on the deformable PDMS membranes were acquired with a 20X, 0.75 NA 
air objective (Plan Apo, Nikon, Japan), using FITC, TRITC, and DAPI filters, respectively. Large images up 
to 6 mm × 6 mm were acquired by using the Custom Multipoint/Large Image function of NIS Elements (NIS 
Elements, Nikon, Japan) in combination with an autofocus routine followed by automated stitching.
Image analysis. Images were analyzed and processed with Fiji (National Institutes of Health, USA). For the 
comparison of the CFD with the experimental results, cells in the selected regions were tracked manually and the 
“Measure” routine was used to determine the area, center of mass as well as the angle of the long axis of a fitted 
ellipse. The latter was used to generate a line plot showing the orientation of the tracked cells (with the line length 
scaled arbitrarily to the length of the fitted ellipse). Angles for the selected regions were plotted for comparison 
with the CFD predicted fluid direction angles in a rose plot using a binning of 15 degrees. Cell density was meas-
ured using the “Analyze Particles” plug-in of Fiji on the fluorescent channel for cell nuclei.
Finite Element Model. A finite element model of the inflation system was created using ABAQUS (Abaqus 
6.9-1, Dassault Systèmes). The model was 2D axial symmetric (x-y plane, x being the radial axis and y being the 
vertical axis). 8-node biquadratic axisymmetric quadrilateral, hybrid, linear pressure, reduced integration ele-
ments were selected for all computations. The constitutive model applied for the PDMS membrane was the one 
determined in our previous investigations on the multiaxial large strain mechanical behavior of the material53. 
The membrane edge was constrained in the vertical and radial direction, to simulate the boundary conditions 
applied in the real system. The pressure loading was applied on the bottom surface of the membrane.
Digital image correlation. Measurement of the deformation field of the inflated membrane was achieved 
by digital image correlation performed using a VIC-3DTM Micro set-up (Correlated Solutions Inc.). VIC-SnapTM 
and VIC-3DTM software were used for image acquisition and post processing. The system allows to reconstruct 
the 3D displacement and field from its interpolation of the corresponding deformation fields. A dedicated 
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inflation system was realized for the strain measurements, identical (in geometry and boundary conditions of the 
inflated membrane) to the one used in the bioreactor.
Speckles were drawn on the membrane using an airbrush system (Harder & Steenbeck Evolution Silverline 
Solo, Germany). Different pressure levels were applied in this investigation (75, 220, 250, and 480 mbar) as well as 
membranes of different thicknesses (in the range 400–500 μ m). Images were acquired with a frequency of 5 Hz.
Prior to the analysis, the region of interest for displacement reconstruction was defined corresponding to 
the part of the membrane which was inflated. The parameters that determine the grid spacing in the analysis 
were automatically assigned based on the image quality. Confidence margin, exhaustive search, and consistency 
threshold were also applied.
Computational Fluid Dynamics model. The flow in the channel with flat and inflated membrane config-
urations was analyzed with a CFD model using ANSYS CFX. Sensitivity analyses (flow rate up to 1.2 l/min, WD 
up to 15%) by conducting a 2-way fluid-structure interaction analysis showed that the interaction between fluid 
forces and membrane deformations are negligible.
The structured mesh with 1.3 × 106 hexahedral elements was developed in ICEM CFD. A previously per-
formed convergence study proved that further mesh refinement does not improve accuracy. All mesh quality 
criteria required by ANSYS CFX were satisfied58.
For all cases the mesh resolution near the membrane surface was selected as such as that the nondimensional 
distance to the first near-membrane grid point
µ ρτ=+y y/ (2)w
would match the recommended criterion
<+y 1 (3)
with y being the distance from the first cell center to the membrane, μ being the fluid viscosity, ρ the density, and 
τW being the WSS. Calculations were performed to quantify fluid-structure interaction effects and these were 
found negligible.
To reduce computational effort only one symmetric half of the channel was modeled. The fluid was modeled 
with a molar mass of 18.02 kg/kmol, a density of 993.3 kg/m3, and a dynamic viscosity of 6.913 × 10−4 kg m−1 s−1. 
This was considered to be a good approximation of the dynamic viscosity of the cell culture medium. As the flow 
rates from 0.1 l/min to 1.2 l/min result in Reynolds numbers of 563 to 7207, the flow regime exhibits transitional 
and turbulent regions59. As shown in Fig. 4A, for the flat membrane configuration, a laminar model could be 
applied up to 0.2 l/min. Due to the flow across the curved surface of the inflated membrane and the high range in 
Reynolds numbers, the two-equation eddy-viscosity Shear Stress Transport (SST) turbulence model60 was used 
for all other cases. The CFX solver accuracy was set to double precision and the root-mean-square values for mass 
conservation and velocity continuity were set to a target of 10−5.
Micro Particle Image Velocimetry. Micro particle image velocimetry (μ PIV) was performed using deion-
ized water as working fluid, seeded with 3.55 μ m fluorescent polystyrene particles (530/607 nm, microParticles 
GmbH). The experimental set-up consisted of an epi-fluorescence microscope system including a 3D stage sys-
tem (LaVision FlowMaster Mitas) in combination with a 532 nm Nd:YAG laser (New Wave, Solo II-15) and a 
2048 × 2048 pixel CCD camera (LaVision Imager ProX 4 M). For image acquisition a 5X, 0.16 NA microscope 
objective was employed (Zeiss EC “Plan-Neofluar”). For data post-processing the commercial software package 
Davis 7 (LaVision) was used. The volume flow of fluids was controlled with a peristaltic pump (P1500, Harvard 
Apparatus) and measured with a flow sensor (PVDF Chemical Flowmeter 0.025–2.5 l/min, B.I.O-TECH e.K., 
Germany). For each flow condition and measurement position 25 two-frame experimental images were acquired 
at a trigger rate of 4 Hz. The cross-correlation technique was used for analysis. The final interrogation window 
of 128 × 128 pixels overlapped by 50%, the corresponding vector spacing was 62.5 μ m. The depth of correla-
tion was determined to be about 124 μ m, following ref. 61. After processing, the 25 experimental images were 
time-averaged. Further details on the experimental set-up have been previously reported in ref. 62.
Statistical analysis. Statistical comparison of cell area for the 3 distinct regions analyzed in Fig. 7 was per-
formed using a non-parametric Mann-Whitney test (α < 0.05). At least 3 independent experiments were ana-
lyzed for each of the respective regions. All quantitative measurements are represented as average ± the standard 
error of the mean.
References
1. Mozaffarian, D. et al. On behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart 
disease and stroke statistics - 2016 update: a report from the American Heart Association. Circulation 133, e38–e360 (2016).
2. Ziaeian, B. & Fonarow, G. C. Epidemiology and aetiology of heart failure. Nat Rev Cardiol 13, 368–378 (2016).
3. Wilhelm, M. J., Ruschitzka, F. & Falk, V. Destination therapy-time for a paradigm change in heart failure therapy. Swiss Med. Wkly. 
143, 1–13 (2013).
4. Dunlay, S. M. & Roger, V. L. Understanding the Epidemic of Heart Failure: Past, Present, and Future. Curr. Heart Fail. Rep. 11, 
404–415 (2014).
5. Silva Enciso, J. Mechanical Circulatory Support: Current Status and Future Directions. Prog. Cardiovasc. Dis. 58, 444–454 (2016).
6. Jaffer, I. H., Fredenburgh, J. C., Hirsh, J. & Weitz, J. I. Medical device-induced thrombosis: What causes it and how can we prevent 
it? J. Thromb. Haemost. 13, S72–S81 (2015).
7. McGuigan, A. P. & Sefton, M. V. The influence of biomaterials on endothelial cell thrombogenicity. Biomaterials 28, 2547–2571 (2007).
www.nature.com/scientificreports/
1 4Scientific RepoRts | 6:38861 | DOI: 10.1038/srep38861
8. Susen, S., Rauch, A., Van Belle, E., Vincentelli, A. & Lenting, P. J. Circulatory support devices: Fundamental aspects and clinical 
management of bleeding and thrombosis. J. Thromb. Haemost. 13, 1757–1767 (2015).
9. Baiguera, S. & Ribatti, D. Endothelialization approaches for viable engineered tissues. Angiogenesis 16, 1–14 (2013).
10. Liu, X. et al. Blood compatible materials: State of the art. J. Mater. Chem. B 2, 5718–5738 (2014).
11. Franco, D. et al. Control of initial endothelial spreading by topographic activation of focal adhesion kinase. Soft Matter 7, 7313 (2011).
12. Liliensiek, S. J. et al. Modulation of human vascular endothelial cell behaviors by nanotopographic cues. Biomaterials 31, 5418–5426 
(2010).
13. Morgan, J. P. et al. Formation of microvascular networks in vitro. Nat. Protoc. 8, 1820–36 (2013).
14. Pang, J. H. et al. In situ Endothelialization: Bioengineering Considerations to Translation. Small 11, 6248–6264 (2015).
15. Li, S. & Henry, J. J. D. Nonthrombogenic approaches to cardiovascular bioengineering. Annu. Rev. Biomed. Eng. 13, 451–75 (2011).
16. Liu, T., Liu, S., Zhang, K., Chen, J. & Huang, N. Endothelialization of implanted cardiovascular biomaterial surfaces: The 
development from in vitro to in vivo. J. Biomed. Mater. Res. - Part A 102, 3754–3772 (2014).
17. Pennel, Z., Zilla, P. & Bezuidenhout, D.  Biomaterials in Vascular Graft Surgery in Reference Module in Materials Science and 
Materials Engineering, doi: http://dx.doi.org/10.1016/B978-0-12-803581-8.02159-7 (Elsevier, 2016).
18. Ren, X. et al. Surface modification and endothelialization of biomaterials as potential scaffolds for vascular tissue engineering 
applications. Chemical Society Reviews 44, 5680–5742 (2015).
19. Kohn, J. C. et al. Cooperative effects of matrix stiffness and fluid shear stress on endothelial cell behavior. Biophys. J. 108, 471–478 
(2015).
20. Dolan, J. M., Meng, H., Sim, F. J. & Kolega, J. Differential gene expression by endothelial cells under positive and negative streamwise 
gradients of high wall shear stress. Am. J. Physiol. Cell Physiol. 305, C854–66 (2013).
21. Dolan, J. M., Meng, H., Singh, S., Paluch, R. & Kolega, J. High fluid shear stress and spatial shear stress gradients affect endothelial 
proliferation, survival, and alignment. Ann. Biomed. Eng. 39, 1620–1631 (2011).
22. Huang, L. & Helmke, B. P. Polarized Actin Structural Dynamics in Response to Cyclic Uniaxial Stretch. Cell. Mol. Bioeng. 8, 160–177 (2015).
23. Franco, D. et al. Accelerated endothelial wound healing on microstructured substrates under flow. Biomaterials 34, 1488–97 (2013).
24. Milde, F. et al. Cell Image Velocimetry (CIV): boosting the automated quantification of cell migration in wound healing assays. 
Integr. Biol. (Camb). 4, 1437–47 (2012).
25. Orsenigo, F. et al. Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of 
vascular permeability in vivo. Nat. Commun. 3, 1208 (2012).
26. Potthoff, E. et al. Toward a rational design of surface textures promoting endothelialization. Nano Lett. 14, 1069–79 (2014).
27. Pakravan, H. A., Saidi, M. S. & Firoozabadi, B. A mechanical model for morphological response of endothelial cells under combined 
wall shear stress and cyclic stretch loadings. Biomech. Model. Mechanobiol. doi: 10.1007/s10237-015-0756-z (2016).
28. Estrada, R. et al. Endothelial Cell Culture Model for Replication of Physiological Profiles. Anal. Chem. 3170–3177 (2011).
29. Tamiello, C., Buskermolen, A. B. C., Baaijens, F. P. T., Broers, J. L. V. & Bouten, C. V. C. Heading in the Right Direction: 
Understanding Cellular Orientation Responses to Complex Biophysical Environments. Cell. Mol. Bioeng. 9, 12–37 (2015).
30. Jufri, N. F., Mohamedali, A., Avolio, A. & Baker, M. S. Mechanical stretch: physiological and pathological implications for human 
vascular endothelial cells. Vasc. Cell 7, 8 (2015).
31. Sinha, R. et al. A medium throughput device to study the effects of combinations of surface strains and fluid-flow shear stresses on 
cells. Lab Chip 15, 429–39 (2014).
32. Zheng, W. et al. A microfluidic flow-stretch chip for investigating blood vessel biomechanics. Lab Chip 12, 3441–50 (2012).
33. Tsukurov, O. I. et al. The Response of Adult Human Saphenous Vein Endothelial Cells to Combined Pressurized Pulsatile Flow and 
Cyclic Strain, In Vitro. Ann. Vasc. Surg. 14, 260–267 (2000).
34. Benbrahim, A. et al. A compliant tubular device to study the influences of wall strain and fluid shear stress on cells of the vascular 
wall. J. Vasc. Surg. 20, 184–194 (1994).
35. Zhao, S. et al. Synergistic Effects of Fluid Shear Stress and Cyclic Circumferential Stretch on Vascular Endothelial Cell Morphology 
and Cytoskeleton. Arterioscler. Thromb. Vasc. Biol. 15, 1781–1786 (1995).
36. Moore, J. E. et al. A device for subjecting vascular endothelial cells to both fluid shear stress and circumferential cyclic stretch. Ann. 
Biomed. Eng. 22, 416–422 (1994).
37. Al-Azawy, M. G., Turan, A. & Revell, A. Assessment of turbulence models for pulsatile flow inside a heart pump. Comput. Methods 
Biomech. Biomed. Engin. 13, 271–285 (2016).
38. Sonntag, S. J. et al. Simulation of a pulsatile total artificial heart: Development of a partitioned Fluid Structure Interaction model. J. 
Fluids Struct. 38, 187–204 (2013).
39. Wittek, A. et al. Cyclic three-dimensional wall motion of the human ascending and abdominal aorta characterized by time-resolved 
three-dimensional ultrasound speckle tracking. Biomech. Model. Mechanobiol. 15, 1–14 (2016).
40. Kroll, M. H., Hellums, J. D., McIntire, L. V., Schafer, A. I. & Moake, J. L. Platelets and shear stress. Blood 88, 1525 LP-1541 (1996).
41. Amaya, R., Pierides, A. & Tarbell, J. M. The Interaction between Fluid Wall Shear Stress and Solid Circumferential Strain Affects 
Endothelial Gene Expression. PLoS One 10, 1–18 (2015).
42. Dancu, M. B. & Tarbell, J. M. Large Negative Stress Phase Angle (SPA) attenuates nitric oxide production in bovine aortic endothelial 
cells. J. Biomech. Eng. 128, 329–34 (2006).
43. Stefopoulos, G., Robotti, F., Falk, V., Poulikakos, D. & Ferrari, A. Endothelialization of Rationally Microtextured Surfaces with 
Minimal Cell Seeding Under Flow. Small 1–14, doi: 10.1002/smll.201503959 (2016).
44. Bartoli, C. R. et al. Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During 
Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding. JACC Hear. Fail. 
3, 860–869 (2015).
45. Robotti, F. et al. The influence of surface micro-structure on endothelialization under supraphysiological wall shear stress. 
Biomaterials 35, 8479–86 (2014).
46. Niklason, L. E. et al. Functional arteries grown in vitro. Science 284, 489–493 (1999).
47. Fry, D. L. Certain histological and chemical responses of the vascular interface to acutely induced mechanical stress in the aorta of 
the dog. Circ. Res. 24, 93–108 (1969).
48. Fry, D. L. Certain Chemorheologic Considerations Regarding the Blood Vascular Interface with Particular Reference to Coronary 
Artery Disease. Circulation 40, IV-38 LP-IV-57 (1969).
49. Kane, R. S., Takayama, S., Ostuni, E., Ingber, D. E. & Whitesides, G. M. Patterning proteins and cells using soft lithography. 
Biomaterials 20, 2363–2376 (1999).
50. Singhvi, R. et al. Engineering cell shape and function. Science. 264, 696 LP-698 (1994).
51. Ren, X. et al. Surface modification and endothelialization of biomaterials as potential scaffolds for vascular tissue engineering 
applications. Chem. Soc. Rev. 44, 5680–5742 (2015).
52. Martinez-Duarte, R. Easy and inexpensive fabrication of PDMS films of different thicknesses. Chips and Tips (Lab on a Chip) (2012). 
Available at: http://blogs.rsc.org/chipsandtips/2012/04/18/easy-and-inexpensive-fabrication-of-pdms-films-of-different-
thicknesses. (Accessed: 15th June 2016).
53. Hopf, R. et al. Experimental and theoretical analyses of the age-dependent large-strain behavior of Sylgard 184 (10:1) silicone 
elastomer. J. Mech. Behav. Biomed. Mater. 60, 425–437 (2016).
www.nature.com/scientificreports/
1 5Scientific RepoRts | 6:38861 | DOI: 10.1038/srep38861
54. Oladipupo, S. et al. VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial 
sprouting. Proc. Natl. Acad. Sci. USA 108, 13264–13269 (2011).
55. Murakami. Fibroblast growth factor regulation of neovascularization. Curr Opin Hematol 15, 215–220 (2008).
56. Lampugnani, M. G. et al. The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, 
beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin). J. Cell Biol. 129, 203–17 (1995).
57. Lampugnani, M. G. et al. Cell confluence regulates tyrosine phosphorylation of adherens junction components in endothelial cells. 
J. Cell Sci. 110 (Pt 1) 2065–77 (1997).
58. ANSYS Inc. ANSYS® Academic Research. ANSYS CFX-Solver Modeling Guide 15317, 448–451 (2013).
59. Patel, V. C. & Head, M. R. Some observations on skin friction and velocity profiles in fully developed pipe and channel flows. J. Fluid 
Mech. 38, 181 (1969).
60. Menter, F. R. Two-equation eddy-viscosity turbulence models for engineering applications. AIAA J. 32, 1598–1605 (1994).
61. Olsen, M. G. & Adrian, R. J. Out-of-focus effects on particle image visibility and correlation in microscopic particle image 
velocimetry. Exp. Fluids 29, (2000).
62. Marschewski, J. et al. Mixing with herringbone-inspired microstructures: overcoming the diffusion limit in co-laminar microfluidic 
devices. Lab Chip 15, 1923–1933 (2015).
Acknowledgements
This project was supported by the “Stiftung PROPTER HOMINES - Vaduz/Fürstentum Liechtenstein”, the 
“Schwyzer-Winiker Stiftung” and the ETH Zurich Foundation. This work is part of the Zurich Heart project of 
Hochschulmedizin Zürich. L.B. would like to thank Rico Muff, Wei-Hsun Lin and Francisco Delgado for the 
LabVIEW support; Jean-Claude Tomasina, Ueli Marti and Tobias Brack for the technical support. L.B. and C.L. 
would like to thank Norina Fellner for the support in the development of the CFD model.
Author Contributions
E.M., D.P. and A.F. designed the study and provided scientific guidance; B.B., L.B. and M.P. developed the 
bioreactor and control system and performed endothelialization experiments; L.B. and M.P. developed 
the mechanical model and L.B. performed the DIC measurements; C.L. and P.E. performed fluid mechanics 
simulations and data analysis; J.M. and C.L. performed the μ PIV experiments and post-processing, M.E. and M.P. 
aided with the development of endothelialization protocols, E.M., D.P. and A.F. wrote the manuscript. All authors 
gave input at various stages during writing.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Bachmann, B. J. et al. A Novel Bioreactor System for the Assessment of 
Endothelialization on Deformable Surfaces. Sci. Rep. 6, 38861; doi: 10.1038/srep38861 (2016).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
 
© The Author(s) 2016
